Multiple Myeloma Coverage from Every Angle

Eric Roeland, MD, on Prophylactic Strategies for Highly Emetogenic Chemotherapy

Posted: Tuesday, February 5, 2019

Eric Roeland, MD, of Massachusetts General Hospital, discusses the wide variation among physicians in preventing vomiting from highly emetogenic chemotherapy.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.